Bouso José Carlos, Doblin Rick, Farré Magí, Alcázar Miguel Angel, Gómez-Jarabo Gregorio
Departamento de Psicología Biológica y de la Salud, Facultad de Psicología, Universidad Autónoma de Madrid, Madrid, Spain.
J Psychoactive Drugs. 2008 Sep;40(3):225-36. doi: 10.1080/02791072.2008.10400637.
The purpose of this study was to investigate the safety of different doses of MDMA-assisted psychotherapy administered in a psychotherapeutic setting to women with chronic PTSD secondary to a sexual assault, and also to obtain preliminary data regarding efficacy. Although this study was originally planned to include 29 subjects, political pressures led to the closing of the study before it could be finished, at which time only six subjects had been treated. Preliminary results from those six subjects are presented here. We found that low doses of MDMA (between 50 and 75 mg) were both psychologically and physiologically safe for all the subjects. Future studies in larger samples and using larger doses are needed in order to further clarify the safety and efficacy of MDMA in the clinical setting in subjects with PTSD.
本研究的目的是调查在心理治疗环境中,对遭受性侵犯继发慢性创伤后应激障碍(PTSD)的女性给予不同剂量摇头丸辅助心理治疗的安全性,并获取有关疗效的初步数据。尽管本研究原计划纳入29名受试者,但政治压力导致研究在完成前就结束了,当时仅治疗了6名受试者。这里展示了这6名受试者的初步结果。我们发现,低剂量的摇头丸(50至75毫克之间)对所有受试者在心理和生理上都是安全的。为了进一步阐明摇头丸在PTSD受试者临床环境中的安全性和疗效,需要在更大样本和使用更大剂量的情况下进行未来研究。